Precision medicine: lessons learned from the SHIVA trial. Lancet Oncol 2015 Dec;16(16):e579-80
Date
12/19/2015Pubmed ID
26678197DOI
10.1016/S1470-2045(15)00397-6Scopus ID
2-s2.0-84961662117 (requires institutional sign-in at Scopus site) 46 CitationsAuthor List
Tsimberidou AM, Kurzrock RAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic AgentsBiomarkers, Tumor
Female
Gene Expression Profiling
Humans
Male
Molecular Diagnostic Techniques
Molecular Targeted Therapy
Neoplasms
Precision Medicine
